The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 03, 2016
Filed:
Nov. 09, 2012
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Msd Italia S.r.l., Rome, IT;
Merck Canada Inc., Kirkland, CA;
Michael T. Rudd, Collegeville, PA (US);
John McCauley, Maple Glen, PA (US);
Nigel Liverton, Harleysville, PA (US);
Christiane Grisé-Bard, Dollard-des-Ormeaux, CA;
Marie-Christine Brochu, St-Laurent, CA;
Sylvie Charron, Laval, CA;
Virender Aulakh, Whitehorse, CA;
Benoit Bachand, Montreal, CA;
Patrick Beaulieu, Laval, CA;
Helmi Zaghdane, Pincourt, CA;
Yongxin Han, Shanghai, CN;
Marco Ferrara, San Donato Milanese, IT;
Steven Harper, Fanwood, NJ (US);
Vincenzo Summa, Rome, IT;
Samuel Chackalamannil, Califon, NJ (US);
Srikanth Venkatraman, Edison, NJ (US);
Unmesh Shah, Watchung, NJ (US);
Francisco Velazquez, Clinton, NJ (US);
MSD Italia S.R.L., Rome, IT;
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.